Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

STAT5 activation is crucial for starting the hair growth phase.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

The mouse hairy ears mutation causes longer ear hair due to changes in gene expression.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Ritlecitinib is safe and may effectively treat alopecia areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Clascoterone is safe for the heart, even at high doses.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Red and black pop bean extracts protect against UV radiation and promote hair growth.

Hair regrowth improved, but quality of life did not.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Topical finasteride is an effective and safer treatment for male hair loss.

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Diet B improved dogs' skin and hair condition.

Upadacitinib effectively treats severe alopecia areata and is safe.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.